Annet van Royen‐Kerkhof

Author

Also Known As

A Van Royen-Kerkhof, A van Royen-Kerkhof, A. Van Royen-Kerkhof, A. van Royen-Kerkhof, A. van Royen‐Kerkhof, Annet VAN ROYEN-KERKHOF, Annet Van Royen-Kerkhof, Annet van Royen-Kerkhof, Annet van Royen‐Kerkhof, Annet van Royen–Kerkhof

Publications

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Wilhelmina Children's Hospital Hospital for Sick Children Radboud University Nijmegen Radboud University Medical Center

About

Annet van Royen‐Kerkhof is an author at University Medical Center Utrecht specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.2K
2	Health Sciences	2	2	30
3	Allergy	2	2	107
4	Engineering	1	1	25
5	Applied Physiology	1	1	17

Annet van Royen‐Kerkhof

Publications

Citations

H-Index

Page 1

	Year	Citations
Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome Sander M. Houten, Wietse Kuis, Marinus Duran, Nature Genetics Cause Hyperimmunoglobulinaemia DPeriodic Fever SyndromeAutoimmune DiseaseDisease MechanismImmunodeficiencies	1999	520
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases Adriana A. de Jesus, Yangfeng Hou, Stephen R. Brooks, Journal of Clinical Investigation Inflammatory Lung DiseaseChronic InterferonLung InflammationImmunodeficienciesImmunology	2019	227
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative Noortje Groot, Nienke de Graeff, Tadej Avčin, Annals of the Rheumatic Diseases	2017	197
Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study Nienke M. ter Haar, E. H. Pieter van Dijkhuizen, Joost F. Swart, Arthritis & Rheumatology	2019	182
European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative Nienke de Graeff, Noortje Groot, Seza Özen, Lara D. Veeken	2018	166
Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations Jennifer W. Leiding, Satoshi Okada, David Hagin, Journal of Allergy and Clinical Immunology Cell TherapyDevelopmental BiologyTransplantationMarrow TransplantationGain-of-function Signal Transducer	2017	158
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative Noortje Groot, Nienke de Graeff, Stephen D. Marks, Annals of the Rheumatic Diseases	2017	154
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis Lisa G. Rider, Rohit Aggarwal, Angela Pistorio, Annals of the Rheumatic Diseases	2017	144
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial Hermine I. Brunner, Nicolino Ruperto, Nikolay Tzaribachev, Annals of the Rheumatic Diseases	2017	120
Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome Satkiran S. Grewal, Robert Wynn, José E. Abdenur, Genetics in Medicine TransplantationMarrow TransplantationBone Marrow FailureEnzyme Replacement TherapyStem Cell Transplantation	2005	93

Page 1